Trials
3 active
3 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Pharmaceutical form: Liquid suspension for injection Route of administration: intramuscular”In the company’s words, NCT06316297 on ClinicalTrials.gov
- Tested for
- Acne (3 trials)
- Main trialPhase 1/2
- “The purpose of this study is to assess the safety profile of intramuscular injections of the Acne mRNA vaccine at 3 dose levels compared with placebo in 12 to 17 years old participants with moderate to severe acne. An early safety data review (ESDR) will be conducted after each subcohort has completed an injection round; enrollment of the next higher dose level subcohort or progression of a subcohort to the subsequent injection round will only proceed if no safety concerns are identified. This sequential process will allow a cautious approach to vaccine injection in the adolescent…”In the company’s words, NCT07756957 on ClinicalTrials.gov
Other drugs for Acne
- TrifaroteneGalderma R&D · Phase 3
- Cyproterone Acetate and Ethinyl EstradiolEurofarma Laboratorios S.A. · Phase 3
- DenifanstatSagimet Biosciences Inc. · Ascletis · Phase 3
- ClascoteroneZhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · Phase 3
- B244AOBiome LLC · Phase 2
- HB0043Huahai Pharmaceutical (Huaota) · Phase 1/2
Coming up3
- 19 Jul 2028Phase 1/2 trial completes · ClinicalTrials.gov
- 30 Nov 2028Phase 1/2 trial completes · ClinicalTrials.gov
- 19 Jun 2029Phase 1/2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 18 NovStatus changed: Not yet recruiting to Recruiting · ClinicalTrials.gov NCT07756957
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 19 Jul 2028 | Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne | |
| Phase 1/2Recruiting | 30 Nov 2028 | Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne | |
| Phase 1/2Recruiting | 19 Jun 2029 | Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026